Comparison of Amoxicillin/Clavulanic Acid High Dose with Cefdinir in the Treatment of Acute Otitis Media
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
10 days of amoxicillin/clavulanic acid high dose and 5 days of cefdinir have been the preferred first- or second-line antibiotics for treatment of children with acute otitis media (AOM) since 2004, as recommended by the American Academy of Pediatrics in the USA, but no head-to-head comparison study has been done.
The purpose of the study was to compare the clinical efficacy of amoxicillin/clavulanic acid high-dose therapy for 10 days with cefdinir therapy for 5 days for AOM at recommended doses.
This was an investigator-blind trial in young children 6–24 months old with no history of recurrent AOM who were randomly assigned to amoxicillin/clavulanic acid (80 mg/kg/day amoxicillin) or cefdinir (14 mg/kg/day), both in two divided doses.
The diagnosis of AOM was based on specific clinical criteria by validated otoscopists at two AOM research centres. The outcome measure for clinical cure was resolution of all symptoms and signs of AOM except for persistence of middle-ear effusion at test-of-cure (TOC) 11–14 days after initiation of antibiotic treatment. Clinical failure was defined as persistence of symptoms and signs of AOM and the need for additional antibiotic therapy. Subjects lost to follow up or who had not taken at least 80% of the prescribed medication were classified as having an indeterminate response. Compliance was monitored using Medical Electronic Monitoring System (MEMS) caps and antibiotic bottle volume measurement at the TOC visit. A logistic regression model was used to estimate the association of age with cure rate. Full interactions in terms of age with treatment were included to estimate any age gradient differential.
A total of 330 children (average age 13.1 months) with AOM were studied. At TOC, 256 children had clinical cure, 69 had clinical failure, and 5 were lost to follow-up. High-dose amoxicillin/clavulanic acid-treated children had a better cure rate (86.5%) than cefdinir-treated patients (71.0%; p = 0.001). Cefdinir was correlated with less frequent cure outcomes as children increased in age between 6 and 24 months. The odds ratios for clinical cure per increasing month of age estimated from a logistic regression model for amoxicillin/clavulanic acid high dose and cefdinir treatment groups was 0.992 (95% CI 0.932, 1.056), p>0.05 and 0.932 (95% CI 0.881, 0.986), p = 0.01. The differences in the odds ratios are significant at p<0.002, indicating a stable clinical cure rate across the ages of children studied for amoxicillin/clavulanic acid and decreasing clinical cure rates as children increased in age for cefdinir.
In children with bona fide AOM for whom clinical outcomes are assessed by validated otoscopists, 10 days of high-dose amoxicillin/clavulanic acid is significantly more effective than 5 days of cefdinir as therapy for AOM. Because of the identified age effect (correlated to child weight), higher doses of cefdinir may have led to a different conclusion; 10 days of cefdinir may also have led to a different conclusion.
- Diagnosis and management of acute otitis media. Pediatrics 113: pp. 1451-65 CrossRef
- Casey, J.R., Block, S., Puthoor, P. (2011) A simple scoring system to improve clinical assessment of acute otitis media. Clin Pediatr (Phila) 50: pp. 623-9 CrossRef
- Block, S.L., McCarty, J.M., Hedrick, J.A. (2000) Comparative safety and efficacy of cefdinir vs. amoxicillin/clavulanate for treatment of suppurative acute otitis media in children. Pediatr Infect Dis J 19: pp. S159-65 CrossRef
- Block, S.L., Busman, T.A., Paris, M.M. (2004) Comparison of five-day cefdinir treatment with ten-day low dose amoxicillin/clavulanate treatment for acute otitis media. Pediatr Infect Dis J 23: pp. 834-8 CrossRef
- Jacobs, M.R., Felmingham, D., Appelbaum, P.C. (2003) The Alexander Project 1998–2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J Antimicrob Chemother 52: pp. 229-46 CrossRef
- Casey, J.R., Pichichero, M.E. (2004) Changes in frequency and pathogens causing acute otitis media in 1995–2003. Pediatr Infect Dis J 23: pp. 824-8 CrossRef
- Block, S.L., Hedrick, J., Harrison, C.J. (2004) Community-wide vaccination with heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr Infect Dis J 23: pp. 829-33 CrossRef
- Casey, J.R., Adlowitz, D.G., Pichichero, M.E. (2010) New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J 29: pp. 304-9
- Cifaldi, M.A., Paris, M.M., Devcich, K.J. (2004) Parent-reported outcomes for treatment of acute otitis media with cefdinir or amoxicillin/clavulanate oral suspensions. Pediatr Drugs 6: pp. 387-93 CrossRef
- Marchant, C.D., Carlin, S.A., Johnson, C.E. (1992) Measuring the comparative efficacy of antibacterial agents for acute otitis media; the “Pollyanna phenomenon.”. J Pediatr 120: pp. 72-7 CrossRef
- Arguedas, A., Dagan, R., Leibovitz, E. (2006) A multicenter, open label, double tympanocentesis study of high dose cefdinir in children with acute otitis media at high risk of persistent or recurrrent infection. Pediatr Inf Dis J 25: pp. 211-8 CrossRef
- Comparison of Amoxicillin/Clavulanic Acid High Dose with Cefdinir in the Treatment of Acute Otitis Media
Volume 72, Issue 15 , pp 1991-1997
- Cover Date
- Print ISSN
- Online ISSN
- Springer International Publishing
- Additional Links
- Industry Sectors
- Author Affiliations
- 1. Legacy Pediatrics, Rochester, NY, USA
- 2. Kentucky Pediatric Research, Bardstown, KY, USA
- 3. Department of Biostatistics & Computational Biology, University of Rochester, Rochester, NY, USA
- 4. Rochester General Hospital Research Institute, Center for Infectious Diseases and Immunology, 1425 Portland Avenue, Rochester, NY, 14621, USA